RARE · Ultragenyx Pharmaceutical Inc. · Documents
$16.08
+0.43 (+2.75%)
At close · Oct 26
Return incl. dividend (before tax)
Market Cap
$1.54B
Shares
98.59M
Volume · Oct 26
3.02M
Avg daily vol (3M)
4.12M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2020-10-26 | — | |
| 8-K | — | 2020-10-23 | — | |
| 8-K | — | 2020-10-13 | 2020-10-08 | |
| 8-K | — | 2020-09-02 | 2020-08-28 | |
| 10-Q | — | 2020-07-30 | 2020-06-30 | |
| 8-K | — | 2020-07-30 | — | |
| 8-K | — | 2020-06-30 | — | |
| 8-K | — | 2020-06-29 | 2020-06-26 | |
| 8-K | — | 2020-06-18 | — | |
| 8-K | — | 2020-05-15 | — | |
| 8-K | — | 2020-05-13 | — | |
| 10-Q | — | 2020-05-07 | 2020-03-31 | |
| 8-K | — | 2020-05-06 | — | |
| DEF 14A | — | 2020-04-29 | 2020-06-26 | |
| DEFA14A | — | 2020-04-29 | — | |
| 8-K | — | 2020-04-01 | 2020-03-31 | |
| 8-K | — | 2020-03-06 | 2020-03-03 | |
| 10-K | — | 2020-02-14 | 2019-12-31 | |
| 8-K | — | 2020-02-13 | — | |
| 8-K | — | 2020-01-13 | — | |
| 8-K | — | 2020-01-09 | — |
Showing 151–171 of 171 filings
Key facts
CIK
1515673
CUSIP
90400D108
13F (30d)
26 filings
26 filers
Visit website
Investor relations